The asymmetrical ROS-METTL3-ESR1 axis in paraspinal muscle progenitor cells determines the progression of adolescent idiopathic scoliosis.

阅读:3
作者:Li Bin, Kuati Amila, Sui Wenyuan, Cai Jinkui, Zhang Tianyuan, Deng Yaolong, Yang Junlin, Lin Xingzuan, Shao Xiexiang
Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity, yet its precise etiology remains elusive. Our previous research highlighted the pivotal role of the asymmetrical ESR1 expression of paraspinal muscle stem/progenitor cells in the progression of AIS. However, the widespread distribution of ESR1 in various organs and tissues limits its safety and efficacy as a therapeutic target. Therefore, it is imperative to investigate the regulatory mechanisms governing the asymmetric ESR1 expression in paraspinal muscle stem/progenitor cells to identify safer and more effective treatment strategies for AIS. Here we discovered elevated levels of reactive oxygen species (ROS) in the concave paraspinal muscles of patients with AIS. The increased ROS decreased the expression of m(6)A methyltransferase METTL3, which further diminished the expression of ESR1 in an m(6)A-dependent manner in concave paraspinal muscle stem/progenitor cells. Thus, the asymmetrical ROS-METTL3-ESR1 axis in paraspinal muscle stem/progenitor cells plays a crucial role in the progression of AIS. Unilateral oxidative stress is one of the causes of AIS through the asymmetrical ROS-METTL3-ESR1 axis in paraspinal muscle stem cells. Furthermore, the antioxidant and methyl donor betaine effectively mitigated the differentiation defects of concave muscle stem/progenitor cells and alleviated the progression of scoliosis through targeting the ROS-METTL3-ESR1 axis. Reducing ROS and increasing METTL3 expression in paraspinal muscle stem cells on the concave side may represent a novel therapeutic strategy for AIS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。